Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Redcentric Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Redcentric şirketinin toplam hissedar öz sermayesi £54.5M ve toplam borcu £43.5M olup, bu da borç-öz sermaye oranını 79.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla £184.5M ve £130.0M dir. Redcentric 'in FAVÖK'ü £3.3M faiz karşılama oranı 0.6 dur. Şirketin £3.1M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

79.9%

Borç/özkaynak oranı

UK£43.52m

Borç

Faiz karşılama oranı	0.6x
Nakit	UK£3.13m
Eşitlik	UK£54.48m
Toplam yükümlülükler	UK£130.02m
Toplam varlıklar	UK£184.51m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Redcentric plc's (LON:RCN) Price In Tune With Revenues

May 21

Some Confidence Is Lacking In Redcentric plc's (LON:RCN) P/E

Sep 21

Redcentric plc's (LON:RCN) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 03

An Intrinsic Calculation For Redcentric plc (LON:RCN) Suggests It's 26% Undervalued

Jan 18

Have Insiders Been Selling Redcentric plc (LON:RCN) Shares This Year?

Dec 14

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: RCN 'nin kısa vadeli varlıkları ( £40.9M ) kısa vadeli yükümlülüklerini ( £53.1M ) kapsamıyor.

Uzun Vadeli Yükümlülükler: RCN 'un kısa vadeli varlıkları ( £40.9M ) uzun vadeli yükümlülüklerini ( £76.9M ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: RCN 'nin net borç/öz sermaye oranı ( 74.1% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: RCN şirketinin borç/öz sermaye oranı son 5 yılda 26.2% seviyesinden 79.9% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: Kârsız olan RCN mevcut pozitif serbest nakit akışı seviyesini koruduğu takdirde 3 yıldan fazla yetecek nakit pistine sahip olacaktır.

Tahmini Nakit Akışı: RCN kârlı değildir ancak serbest nakit akışı pozitif olsa ve yılda 4.3 % oranında azalsa bile 3 yıldan fazla bir süre yetecek nakit akışına sahiptir.

Redcentric Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Redcentric plc Announces Board Changes

CEO & Executive Director exercised options and sold UK£92k worth of stock

Full year 2024 earnings released: UK£0.022 loss per share (vs UK£0.059 loss in FY 2023)

Redcentric plc Recommends Final Dividend for 2024, Expects to Be Paid on 24 January 2025

Redcentric plc Announces Company Secretary Changes

New minor risk - Financial data availability

Redcentric Confirms Early Stages of Discussions with Wiit Regarding a Possible Offer for the Entire Issued and to be Issued Share Capital of Redcentric

Redcentric plc's (LON:RCN) Price In Tune With Revenues

Redcentric plc, Annual General Meeting, Sep 18, 2024

Upcoming dividend of UK£0.012 per share

Redcentric plc Appoints Michelle Senecal De Fonseca as Non-Executive Director, Chair of the Remuneration Committee and Member of the Audit and Nomination Committees

Less than half of directors are independent

Upcoming dividend of UK£0.024 per share at 2.9% yield

First half 2024 earnings released: UK£0.001 loss per share (vs UK£0.039 loss in 1H 2023)

Redcentric plc Declares Interim Dividend for the Six Months Ended 30 September 2023, Payable on 18 April 2024

Redcentric plc Recommends Final Dividend for the Year 2023, Payable on January 19, 2024

Redcentric plc to Report Fiscal Year 2023 Results on Aug 24, 2023

Redcentric plc Reiterates Earnings Guidance for the Fiscal Year 2023

New minor risk - Financial data availability

Consensus forecasts updated

Redcentric plc to Report First Half, 2024 Results on Nov 22, 2023

First half 2023 earnings released: EPS: UK£0.023 (vs UK£0.018 in 1H 2022)

Redcentric plc Announces an Interim Dividend, Payable on 27 January 2023

Consensus forecasts updated

High number of new and inexperienced directors

Redcentric plc Provides Earnings Guidance for the Year 2023

Some Confidence Is Lacking In Redcentric plc's (LON:RCN) P/E

High number of new and inexperienced directors

Consensus forecasts updated

Full year 2022 earnings released: EPS: UK£0.044 (vs UK£0.06 in FY 2021)

Redcentric plc Recommends Final Dividend for the Fiscal Year 2022, Payable on September 16, 2022

Redcentric plc Announces Management Changes

High number of new and inexperienced directors

CEO & Executive Director exercised options and sold UK£255k worth of stock

First half 2022 earnings released: EPS UK£0.017 (vs UK£0.014 in 1H 2021)

Redcentric plc's (LON:RCN) CEO Compensation Is Looking A Bit Stretched At The Moment

Redcentric's (LON:RCN) Earnings Are Of Questionable Quality

Upcoming dividend of UK£0.024 per share

Estimating The Fair Value Of Redcentric plc (LON:RCN)

Senior Independent Non-Executive Director has left the company

What Kind Of Investors Own Most Of Redcentric plc (LON:RCN)?

An Intrinsic Calculation For Redcentric plc (LON:RCN) Suggests It's 26% Undervalued

CEO & Executive Director exercised options and sold UK£107k worth of stock

Redcentric plc has completed a Follow-on Equity Offering in the amount of £38.5 million.

New 90-day low: UK£1.19

Have Insiders Been Selling Redcentric plc (LON:RCN) Shares This Year?

First half 2021 earnings released: EPS UK£0.014

End of Formal Sale Process and Starts Discussions with Interested Parties

New 90-day low: UK£1.23

New 90-day low: UK£1.26

Redcentric plc to Report First Half, 2021 Results on Nov 17, 2020

Price target raised to UK£1.83

Insider recently sold UK£117.4k worth of stock

New 90-day high - UK£1.55

Full year earnings released - UK£0.071 loss per share

New 90-day high - UK£1.53

Redcentric plc to Report Fiscal Year 2020 Final Results on Aug 11, 2020

New 90-day high - UK£1.32

Redcentric plc has completed a Follow-on Equity Offering in the amount of £5.775 million.

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin